Medicinal Chemistry

Synthesis, Anticancer and Molecular Docking Studies of 2-(4-chlorophenyl)-5-aryl-1,3,4-Oxadiazole Analogues

Abstract

Mohamed Jawed Ahsan, Vikram Pratap Singh Rathod, Monika Singh, Ramdayal Sharma, Surender Singh Jadav, Sabina Yasmin, Salahuddin and Pradeep Kumar

Among a series of ten, 2-(4-chlorophrnyl)-5-aryl-1,3,4-oxadiazole analogs, 4c showed maximum activity on various cancer cell lines, with average growth percent of 95.37%. The molecular docking studies for the compounds 4a & 4c showed that the residue Cys797 is present near to the para substitution of phenyl group while the five member oxadiazole ring of ligandswas lying near to Leu792 and Met 793 of EGFR tyrosine kinase active